ATYPICAL HEMOLYTIC UREMIC

Clinical trials for ATYPICAL HEMOLYTIC UREMIC explained in plain language.

Never miss a new study

Get alerted when new ATYPICAL HEMOLYTIC UREMIC trials appear

Sign up with your email to follow new studies for ATYPICAL HEMOLYTIC UREMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New treatment tested for rare blood disorder in china

Disease control Completed

This study tested whether the drug eculizumab can help control atypical hemolytic uremic syndrome (aHUS), a rare blood disorder that can damage kidneys. The trial included 25 Chinese children and adults who hadn't previously tried similar complement inhibitor treatments. Particip…

Matched conditions: ATYPICAL HEMOLYTIC UREMIC

Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

ATYPICAL HEMOLYTIC UREMIC

Get alerted when new ATYPICAL HEMOLYTIC UREMIC trials appear

New treatment tested for rare blood disorder in china